Clinical Trials Logo
  1. Home
  2. Cytomegalovirus Retinitis
  3. NCT04831333

Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis

Cytomegalovirus Retinitis Clinical Trial

Official title:
Deep Learning-based System for Detection of AIDS-related Cytomegalovirus Retinitis in Ultra-Widefield Fundus Images

Clinical Trial Summary

Ophthalmological screening for cytomegalovirus retinitis (CMVR) for HIV/AIDS patients is important. However, the manual screening with fundus imaging is laborious and subjective. Deep learning (DL) system has been developed for the automated detection of various eye diseases with high accuracy and efficiency, including diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), papilledema, lattice degeneration and retinal breaks, from ocular fundus photographs. UWF imaging is a relatively new imaging modality for DL system but has also shown extraordinary talents in automatic retinal analysis With the press for routine CMVR screening in AIDS patients and the great capacity of DL system, the use of deep learning (DL) system to AIDS-related CMVR with Ultra-Widefield (UWF) fundus images is promising. The investigators previously developed a DL system to detect AIDS-related CMVR. For further evaluating the applicability of the DL system, a prospective dataset is needed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04831333
Study type Observational [Patient Registry]
Source Beijing YouAn Hospital
Contact
Status Completed
Phase
Start date April 1, 2021
Completion date May 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT00000135 - Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Phase 2/Phase 3
Completed NCT00000118 - Ganciclovir Implant Study for Cytomegalovirus Retinitis Phase 3
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT00000143 - Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Phase 3
Completed NCT01866397 - Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Phase 4
Completed NCT00004794 - Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Phase 2
Completed NCT00000136 - Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Phase 3
Completed NCT00091884 - Efficacy of Elevated CD4 Counts on CMV Retinitis N/A
Recruiting NCT05911503 - Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis Early Phase 1
Completed NCT00002377 - A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Phase 3
Completed NCT00001611 - Immune Activity Against CVM Retinitis N/A
Completed NCT00000134 - Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Phase 3
Completed NCT00000168 - Longitudinal Study of Ocular Complications of AIDS (LSOCA) N/A
Active, not recruiting NCT00002301 - A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir N/A
Active, not recruiting NCT00002384 - A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS N/A
Active, not recruiting NCT00017784 - Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Phase 3
Completed NCT00001034 - The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV Phase 2
Completed NCT00002257 - A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS N/A
Completed NCT00002134 - A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis N/A
Completed NCT00000673 - A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy Phase 1